Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EIS-12656Phase 21 trial
Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency
- enpulimabPhase 21 trial
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Advanced Solid Tumor
- ENV-501Phase 21 trial
Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer
- EP0062Phase 21 trial
Ellipses Pharma · Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer
- EP0089-101Phase 21 trial
Ellipses Pharma · Solid Cancers, Solid Tumours
- epacadostatPhase 21 trial
Incyte · Endometrial Cancer
- ERAS-0015Phase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- ERAS-601Phase 21 trial
Erasca, Inc. · Advanced or Metastatic Solid Tumors
- ES014Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Desmoid Tumor
- ES102Phase 21 trial
Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer
- ETX-19477Phase 21 trial
858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer
- ETX-636Phase 21 trial
Ensem Therapeutics · Advanced Solid Tumors, Advanced Breast Cancer
- ETX-929Phase 21 trial
Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer
- EvalstotugBA3071Phase 21 trial
BioAtla, Inc. · Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck
- EvexomostatSDX-7320Phase 21 trial
SynDevRx, Inc. · HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
- EVM14Phase 21 trial
Everest Medicines (Beijing) Co., Ltd. · Selected Types of Solid Tumor
- EVX-01Phase 21 trial
Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma
- FamitinibSHR-1020Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Recurrent or Metastatic Cervical Cancer
- Farletuzumab ecteribulinMORAb-202Phase 21 trial
Eisai · Solid Tumor
- FB-1603Phase 21 trial
Febico Biomedical Corp. · Hepatocellular Carcinoma
- FB849dose-escalation FB849, dose-expansion of FB849Phase 21 trial
1ST Biotherapeutics, Inc. · Advanced Solid Tumor
- FC084CSAPhase 21 trial
FindCure Biosciences (ZhongShan) Co., Ltd. · Advanced Malignant Solid Tumors
- FDC fianlimabPhase 21 trial
Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)
- FF-10832Gemcitabine LiposomePhase 21 trial
Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer
- FG-3246FOR46Phase 21 trial
Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer
- FG001Optical imaging agent FG001, Fluorescent imaging agent FG001Phase 21 trial
FluoGuide A/S · High-Grade Glioma (WHO III-IV)
- FID007Paclitaxel in Polyethyloxazoline Polymer, Nanoencapsulated Paclitaxel FID-007Phase 21 trial
Fulgent Pharma LLC. · Head and Neck Squamous Cell Carcinoma
- FinotonlimabPhase 21 trial
Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma
- Fixed cemiplimabPhase 21 trial
Regeneron · Melanoma
- FluvustatPhase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer
- FluzoparibPhase 21 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors
- FLX475tivumecirnonPhase 21 trial
RAPT Therapeutics, Inc., a member of the GSK plc group of companies · Advanced Cancer
- FMC-242Phase 21 trial
Frontier Medicines Corporation · Locally Advanced Solid Tumor
- FOG-001Phase 21 trial
Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor
- Ga-68-NGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- GAd-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- GAd20-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- gavo-celPhase 21 trial
TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura
- GB268Phase 21 trial
Eddingpharm (Zhuhai) Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic)
- GDC-1261Phase 21 trial
Roche (Genentech) · Advanced Prostate Cancer, Metastatic Prostate Cancer
- GDC-4198RGT-419B, RO7840734Phase 21 trial
Roche (Genentech) · Breast Cancer
- GEN-725Phase 21 trial
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- GEN1042Phase 21 trial
Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
- GFH925Phase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Advance Non-small Cell Lung Cancer
- GFS202APhase 21 trial
Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer
- GI-101Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-101APhase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer
- GI-108Phase 21 trial
GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
- GIM-531Phase 21 trial
Georgiamune Inc · Melanoma Stage IV, Solid Tumor
- GLS-012Phase 21 trial
Guangzhou Gloria Biosciences Co., Ltd. · Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.